Request Free Sample
×
At Home Cancer Testing Market
ID: MRFR/HC/35101-HCR
100 Pages
October 2025
Marktforschungsbericht für Krebstests zu Hause nach Testtyp (Gentests, Biomarkertests, immunologische Tests, zellfreie DNA-Tests), nach Probentyp (Blutprobe, Speichelprobe, Urinprobe, Gewebeprobe), nach Vertriebskanal (Online-Apotheken, Einzelhandelsapotheken, Direktvertrieb), nach Endbenutzer (Einzelpersonen, medizinisches Fachpersonal, Forschungseinrichtungen) und nach Regionen (Nordamerika, Europa, Südamerika, Asien-Pazifik, Naher Osten und Afrika) - Prognose bis 2034
Zu den wichtigsten Unternehmen im At Home Cancer Testing Market-Markt gehören
Berichtsumfang
FAQs
What is the current valuation of the At-Home Cancer Testing Market?
The At-Home Cancer Testing Market was valued at 3.74 USD Billion in 2024.
What is the projected market size for the At-Home Cancer Testing Market by 2035?
The market is projected to reach 19.91 USD Billion by 2035.
What is the expected CAGR for the At-Home Cancer Testing Market during the forecast period?
The expected CAGR for the market from 2025 to 2035 is 16.42%.
Which companies are considered key players in the At-Home Cancer Testing Market?
Key players include Exact Sciences, GRAIL, Guardant Health, Foundation Medicine, Caris Life Sciences, OncoOne, Biocept, and NantHealth.
What are the main types of testing in the At-Home Cancer Testing Market?
The main types of testing include Genetic Testing, Biomarker Testing, Immunological Testing, and Cell-free DNA Testing.
How does the market segment by sample type?
The market segments by sample type include Blood Sample, Saliva Sample, Urine Sample, and Tissue Sample.
What distribution channels are utilized in the At-Home Cancer Testing Market?
Distribution channels include Online Pharmacies, Retail Pharmacies, and Direct-to-Consumer sales.
Who are the primary end users of At-Home Cancer Testing products?
Primary end users consist of Individuals, Healthcare Professionals, and Research Institutions.
What was the market valuation for Genetic Testing in 2024?
In 2024, the market valuation for Genetic Testing was 0.74 USD Billion.
What is the projected valuation for Biomarker Testing by 2035?
Biomarker Testing is projected to reach 5.83 USD Billion by 2035.
Kostenloses Muster herunterladen
Bitte füllen Sie das folgende Formular aus, um ein kostenloses Muster dieses Berichts zu erhalten
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Fallstudie
Aerospace & Defense
Einen Kommentar hinterlassen